Novo Holdings A/S
CIK: 0001388325Latest portfolio: $1.3B · Q4 2025
Holdings
24
Total Value
$1.3B
New Positions
1
Closed Positions
4
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | BNBROOKFIELD CORP | 3,496,245 | $160.4M | 12.46% | +1.2M | |
| 2 | EWTXEDGEWISE THERAPEUTICS INC | 5,350,000 | $132.8M | 10.31% | — | |
| 3 | ASMLASML HOLDING N V | 113,946 | $121.9M | 9.47% | -31,890 | |
| 4 | MIRMMIRUM PHARMACEUTICALS INC | 1,264,028 | $99.8M | 7.75% | — | |
| 5 | CRMSALESFORCE INC | 330,187 | $87.5M | 6.79% | — | |
| 6 | CRNXCRINETICS PHARMACEUTICALS IN | 1,625,000 | $75.6M | 5.87% | — | |
| 7 | VRDNVIRIDIAN THERAPEUTICS INC | 2,380,000 | $74.1M | 5.75% | — | |
| 8 | MPLTMAPLIGHT THERAPEUTICS INC | 3,686,622 | $64.8M | 5.03% | NEW | |
| 9 | ZBIOZENAS BIOPHARMA INC | 1,450,000 | $52.6M | 4.09% | -550,000 | |
| 10 | PHVSPHARVARIS N V | 1,750,000 | $48.6M | 3.77% | — | |
| 11 | APGEAPOGEE THERAPEUTICS INC | 570,000 | $43.0M | 3.34% | +70K | |
| 12 | PCVXVAXCYTE INC | 916,160 | $42.3M | 3.28% | — | |
| 13 | BMRNBIOMARIN PHARMACEUTICAL INC | 660,000 | $39.2M | 3.05% | — | |
| 14 | AVBPARRIVENT BIOPHARMA INC | 1,942,142 | $39.1M | 3.03% | — | |
| 15 | BABAALIBABA GROUP HLDG LTD | 257,327 | $37.7M | 2.93% | — | |
| 16 | IM8NINSMED INC | 200,000 | $34.8M | 2.70% | — | |
| 17 | TCE2CELLDEX THERAPEUTICS INC NEW | 1,200,000 | $32.6M | 2.53% | — | |
| 18 | FDMT4D MOLECULAR THERAPEUTICS IN | 3,650,737 | $27.4M | 2.13% | +1.7M | |
| 19 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 1,961,317 | $24.6M | 1.91% | — | |
| 20 | ELVNENLIVEN THERAPEUTICS INC | 1,480,000 | $22.8M | 1.77% | +54K | |
| 21 | VALNVALNEVA SE | 2,305,000 | $20.3M | 1.58% | -40,000 | |
| 22 | LNZALANZATECH GLOBAL INC | 158,148 | $2.2M | 0.17% | — | |
| 23 | MQMARQETA INC | 441,558 | $2.1M | 0.16% | — | |
| 24 | IOBTIO BIOTECH INC | 2,512,453 | $1.5M | 0.12% | — |
Quarterly Changes
New Positions
- MPLTNEW$64.8M
Sector Breakdown
Healthcare0.0% ($1.3276099845756438e+70T)
Technology0.0% ($121906.9T)
Unknown0.0% ($3.5T)
Financial Services0.0% ($160.4M)
Consumer Cyclical0.0% ($37.7M)
Industrials0.0% ($2.2M)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $1.3B | 24 |
| Q3 2025 | Nov 14, 2025 | $1.6T | 27 |
| Q2 2025 | Aug 14, 2025 | $1.4T | 29 |
| Q1 2025 | May 15, 2025 | $1.3T | 31 |
| Q4 2024 | Feb 14, 2025 | $1.7T | 34 |
| Q3 2024 | Oct 24, 2024 | $2013.4T | 37 |
| Q2 2024 | Aug 14, 2024 | $1722.4T | 39 |
| Q1 2024 | May 15, 2024 | $1449.7T | 35 |
| Q4 2023 | Feb 14, 2024 | $1619.3T | 36 |
| Q3 2023 | Nov 14, 2023 | $1353.2T | 40 |
| Q2 2023 | Aug 14, 2023 | $1294.2T | 41 |
| Q1 2023 | May 15, 2023 | $1515.6T | 47 |
| Q4 2022 | Feb 14, 2023 | $1601.6T | 48 |
| Q3 2022 | Nov 14, 2022 | $2.1T | 52 |
| Q2 2022 | Aug 15, 2022 | $2.0T | 54 |
| Q1 2022 | May 16, 2022 | $2.4T | 53 |
| Q4 2021 | Feb 14, 2022 | $2.1T | 48 |
| Q3 2021 | Nov 15, 2021 | $1.9T | 49 |
| Q2 2021 | Aug 16, 2021 | $2.3T | 54 |
| Q1 2021 | May 17, 2021 | $2.4T | 51 |
| Q4 2020 | Feb 16, 2021 | $2.3T | 45 |
| Q3 2020 | Nov 16, 2020 | $2.0T | 42 |
| Q2 2020 | Aug 14, 2020 | $1.5T | 35 |
| Q1 2020 | May 15, 2020 | $1.5T | 30 |
| Q4 2019 | Feb 14, 2020 | $1.6T | 29 |
| Q3 2019 | Nov 14, 2019 | $583.7B | 29 |
| Q2 2019 | Aug 14, 2019 | $713.8B | 29 |
| Q1 2019 | May 15, 2019 | $676.0B | 22 |
| Q4 2018 | Feb 14, 2019 | $710.3B | 23 |
| Q3 2018 | Nov 14, 2018 | $1.3T | 22 |
| Q2 2018 | Aug 14, 2018 | $991.1B | 18 |
| Q1 2018 | May 15, 2018 | $797.4B | 17 |
| Q4 2017 | Feb 14, 2018 | $713.4B | 14 |
| Q3 2017 | Nov 14, 2017 | $768.3B | 17 |
| Q2 2017 | Aug 14, 2017 | $835.8B | 21 |
| Q1 2017 | May 15, 2017 | $939.1B | 22 |
| Q4 2016 | Feb 14, 2017 | $1.1T | 22 |
| Q3 2016 | Nov 14, 2016 | $1.1T | 17 |
| Q2 2016 | Aug 15, 2016 | $952.6B | 18 |
| Q1 2016 | May 16, 2016 | $912.5B | 17 |
Fund Information
Novo Holdings A/S is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $1.3B across 24 holdings. The largest position is BROOKFIELD CORP (BN), representing 12.5% of the portfolio. Compared to the previous quarter, the fund opened 1 new positions and closed 4 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.